Pharmaceuticals, Biotechnology and Life Sciences
TURNHOUT, Belgium & EDMONTON, Canada–(BUSINESS WIRE)–MindBytes BVBA and its subsidiary, MindLab Interactive AI Inc., (“MindBytes”) today announced that its first…
Company to focus on benefits of CBD for non-addictive pain management and opioid, alcohol addiction recovery NEWPORT BEACH, Calif.–(BUSINESS WIRE)–lt;a…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of…
Industry leaders partner to help life sciences companies compliantlymanage global events
HIGH POINT, N.C.–(BUSINESS WIRE)–vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the first quarter that ended March 31, 2019,…
Highlights Net business wins (including pass-through) in the quarter of $885 million; a book to bill of 1.31. Closing backlog…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization…
Brings 35+ Years of Industry and Regulatory Expertise to Board LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq:SLP), the premier provider of…
– COSMIC-313 is the third phase 3 pivotal trial to investigate cabozantinib in combination with immune checkpoint inhibitors – ALAMEDA,…
Updates Fiscal 2019 Guidance EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro…